Cargando…
Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil
Each year, 4.3 million pregnant women are exposed to malaria risk in Latin America and the Caribbean. Plasmodium vivax causes 76% of the regional malaria burden and appears to be less affected than P. falciparum by current elimination efforts. This is in part due to the parasite's ability to st...
Autores principales: | Corder, Rodrigo M., de Lima, Antonio C. P., Khoury, David S., Docken, Steffen S., Davenport, Miles P., Ferreira, Marcelo U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423143/ https://www.ncbi.nlm.nih.gov/pubmed/32735631 http://dx.doi.org/10.1371/journal.pntd.0008526 |
Ejemplares similares
-
Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
por: Reddy, Pavani, et al.
Publicado: (2006) -
Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax
por: Rajgor, D. D., et al.
Publicado: (2014) -
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019) -
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019) -
Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Watson, James A., et al.
Publicado: (2022)